DENVER—An experimental iron-based phosphate binder is effective for treating hyperphosphatemia in hemodialysis (HD) patients, and is well tolerated, new data show. James A. Tumlin, MD, and colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results